Skip to main content
Fig. 7 | BMC Cancer

Fig. 7

From: Prospective pharmacological methodology for establishing and evaluating anti-cancer drug resistant cell lines

Fig. 7

Comparison of the IC, GI, and GR parameters in evaluating anti-cancer drug resistance. The graph shown in the second column of Fig. 8A were analyzed in three respects. The same analyses were conducted for the IC50, GI100, and GR100. The number of cells corresponding to the IC50 in (A), GI100 in (B), and GR100 in (C) is indicated by a horizontal line. Data from the control groups not exposed to drugs are shown in the left column, the resistant groups exposed to sunitinib are shown in the middle column, and the resistance reversible groups are shown in the right column

Back to article page